Chinese API Maker Cited Over Data Integrity in FDA Warning Letter

By Sam | February 28, 2017

A Chinese API maker relied on manipulated data and incomplete records to make decisions on batch releases, prompting the FDA to issue a warning letter to the company over data integrity.
Source: Drug Industry Daily

Posted in Drug Industry Daily